BioInvent to Host Key Opinion Leader Call on Enhancing Checkpoint Inhibitors for the Treatment of Solid Cancers |
| July 13, 2020 | July 2020 Bond Updates |
|
LUND, Sweden, July 13, 2020 /PRNewswire/ -- Call & Webcast on Tuesday, July 21 at 10 a.m. Eastern Time BioInvent International AB ("BioInvent" or the "Company") (OMXS: BINV) ), a biotech company focused on the discovery and development of novel and first-in-class immune-modulatory... |
| View more at: https://www.prnewswire.com:443/news-releases/bioinvent-to-host-key-opinion-leader-call-on-enhancing-checkpoint-inhibitors-for-the-treatment-of-solid-cancers-301092041.html |
| Related News |
|